Provepharm recalls 1 mg/mL Dihydroergotamine injection ampules due to discoloration. This may indicate instability and affect safety. Consumers should contact the manufacturer for details.
Discoloration
Provepharm is recalling 1 mg/mL Dihydroergotamine Mesylate injection ampules because discoloration could indicate instability. This may affect the product's safety and effectiveness.
Discoloration in the injection ampules may indicate the product has become unstable. This could affect the product's safety and effectiveness, though it does not pose an immediate risk of serious injury.
Prescription users of Dihydroergotamine injection ampules with specific lot numbers and expiration dates. Those who have the product are most at risk.
Check for discoloration in the ampules. The affected products have lot numbers F9026F01 or F9026F02 and expire by December 2025.
Inspect the injection ampules for any discoloration before use.
Discoloration may indicate the product has become unstable, which could affect its safety and effectiveness.
Lot numbers F9026F01 and F9026F02 are affected.
The products expire by December 2025.
We’ve drafted a message you can send Provepharm to request your refund or repair — edit it as you like.
Subject: Recall D-0150-2025 — Provepharm Provepharm Hello, I own a Provepharm that is covered by recall D-0150-2025 from Provepharm. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
